1)Swerdlow SH, Campo E, Harris NL, et al:WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues, 4th ed, IARC Press, Lyon,2008
2)鈴宮淳司:悪性リンパ腫(リンパ系増殖性疾患).スタンダード検査血液学 第3版(日本検査血液学会編),医歯薬出版,pp295-314,2014
3)Swerdlow SH, Jaffe ES, Brousset P, et al:Cytotoxic T-cell and NK-cell lymphomas: current questions and controversies. Am J Surg Pathol 38:e60-e71,2014
4)Inghirami G, Chan WC, Pileri S:Peripheral T-cell and NK cell lymphoproliferative disorders: cell of origin, clinical and pathological implications. Immunol Rev 263:124-159,2015
5)大島孝一:リンパ腫のWHO分類(2008),成熟性T細胞およびNK細胞腫瘍.日臨 73(Supple8):249-257,2015
6)Swerdlow SH, Campo E, Pileri SA, et al:The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127:2375-2390,2016
7)鈴宮淳司:リンパ球系腫瘍総論.造血器腫瘍アトラス 改訂第5版(谷脇雅史,横田昇平,藤田純也編),日本医事新報社,pp456-468,2016
8)Hu S, Young KH, Konoplev SN, et al:Follicular T-cell lymphoma: a member of an emerging family of follicular helper T-cell derived T-cell lymphomas. Hum Pathol 43:1789-1798,2012
9)坂田(柳元)麻実子,千葉滋:血管免疫芽球性T細胞リンパ腫の分子学的な発症機序.臨血 57:1038-1043,2016
10)Iqbal J, Wright G, Wang C, et al:Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. Blood 123:2915-2923,2014
11)Agnelli L, Mereu E, Pellegrino E, et al:Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma. Blood 120:1274-1281,2012
12)Srinivasa DR, Miranda RN, Kaura A, et al:Global Adverse Event Reports of Breast Implant-Associated ALCL: An International Review of 40 Government Authority Databases. Plast Reconstr Surg,2017,in press
13)菅谷誠,河合一浩,大塚幹夫,他:皮膚リンパ腫診療ガイドライン2011年改訂版(日本皮膚科学会編).日皮会誌 122:1513-1531,2012(https://www.dermatol.or.jp/uploads/uploads/files/guideline/1372907289_2.pdf)(2017年6月2日アクセス)
14)日本小児感染症学会(監):慢性活動性EBウイルス感染症とその類縁疾患の診療ガイドライン2016,診断と治療社,2016